Results 251 to 260 of about 1,947,729 (286)

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Lancet, The, 2021
Arnaud Scherpereel, Anna K Nowak, Nobukazu Fujimoto   +2 more
exaly  

Line Graph

2021
openaire   +1 more source

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Lancet, The, 2021
Ahmet Sezer, Saadettin Kilickap, Igor N Bondarenko   +2 more
exaly  

Hematology and oncology clinical care during the coronavirus disease 2019 pandemic

Ca-A Cancer Journal for Clinicians, 2020
Manish A Shah, Tsiporah B Shore, Sebastian Mayer   +2 more
exaly  

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Marsela Braunstein, Amit M Oza, Stephanie Lheureux   +2 more
exaly  

Cancer Disparities by Race/Ethnicity and Socioeconomic Status

Ca-A Cancer Journal for Clinicians, 2004
Gopal K Singh
exaly  

Line Graphs and Line Digraphs

2021
Lowell W. Beineke, Jay S. Bagga
openaire   +1 more source

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

Ca-A Cancer Journal for Clinicians, 2016
Markus Raderer, Barbara Kiesewetter
exaly  

Advances in Prostate Cancer Chemotherapy: A New Era Begins

Ca-A Cancer Journal for Clinicians, 2005
Kenneth J Pienta, David C Smith
exaly  

Line graphs

2007
openaire   +1 more source